Latest Breaking News On - கூட்டங்கள் படிப்புகள் ப்ரோக்ர்யாம் - Page 1 : comparemela.com

Northwell Health and Cold Spring Harbor Laboratory open virtual COVID-19 clinical trial for non-hospitalized patients By Staff 2 months ago An outpatient, digital, randomized clinical trial will look at the safety and efficacy of famotidine (PEPCID) to treat mild to moderate Covid-19 MANHASSET, N.Y.–(BUSINESS WIRE)–The Feinstein Institutes for Medical Research and Cold Spring Harbor Laboratory (CSHL) are recruiting patients in a fully virtual, in-home, randomized, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of famotidine, or PEPCID, for the outpatient treatment of the novel coronavirus disease 2019 (COVID-19) in adults. Sold over-the-counter as PEPCID, famotidine is a histamine 2 blocker used to decrease stomach acid and this clinical trial will assess its use as a COVID-19 therapy.

New yorkUnited statesPershing squareCold spring harbor laboratoryKevinj traceyTobias janowitzNorthwell home labNorthwell health is new yorkNational cancer instituteNorthwell healthNorthwell health physician partnersPershing square foundationMeetings courses programHofstra northwell school of nursingFeinstein institutes for medical researchFeinstein institutes